Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER
Close

Altimmune Inc (ALT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Altimmune's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
11.28 +0.49    +4.54%
02/12 - Closed. Currency in USD ( Disclaimer )
After Hours
11.44
+0.16
+1.42%
18:41:28 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,057,173
  • Bid/Ask: 11.20 / 11.44
  • Day's Range: 10.53 - 11.33
Altimmune 11.28 +0.49 +4.54%

Altimmune Inc Company Profile

 
Get an in-depth profile of Altimmune Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology
SectorHealthcare
Employees

47

Equity Type

ORD

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company’s lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Contact Information

Top Executives

Name Age Since Title
Wayne F. Pisano 66 2018 Independent Director
David J. Drutz 82 2011 Independent Director
Mitchel B. Sayare 73 2010 Independent Chairman
John Petricciani 85 - Member of Scientific Advisory Board
Diane Kathryn Jorkasky 69 2020 Independent Director
Richard James Whitley 75 - Member of Scientific Advisory Board
Philip L. Hodges 52 2017 Independent Director
Klaus O. Schafer 71 2012 Independent Director
John M. Gill 69 2004 Independent Director
Vipin K. Garg 63 2018 President, CEO & Director
Naga Chalasani - 2022 Member of Nash Scientific Advisory Board
Daniel J. Drucker - 2022 Member of Obesity Scientific Advisory Board
Samuel Klein - 2022 Member of Obesity Scientific Advisory Board
Mazen Noureddin - 2022 Member of Nash Scientific Advisory Board
Donna Ryan - 2022 Member of Obesity Scientific Advisory Board
Caroline M. Apovian - 2022 Member of Obesity Scientific Advisory Board
Louis J. Aronne 66 2022 Member of Obesity Scientific Advisory Board
Juan Pablo Frias - 2022 Member of Obesity Scientific Advisory Board
Stephen A. Harrison - 2022 Member of Nash Scientific Advisory Board
Michael Charlton - 2022 Member of Nash Scientific Advisory Board
Robert F. Kushner - 2022 Member of Obesity Scientific Advisory Board
Rohit Loomba - 2022 Member of Nash Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ALT Comments

Write your thoughts about Altimmune Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Giuseppe Giannachi
Giuseppe Giannachi Sep 14, 2022 12:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone around?
Jack Nicholson
Jack Nicholson Aug 12, 2021 12:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I've seen this one before, it looks like a come back but when I buy it, it goes down to a dollar. I'm not buying it though so it will probably do great ;o)
Ken Burian
Ken Burian Aug 12, 2021 12:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lol. i would recommend you buy the stock and put in a stop loss to limit the potential damage for a speculative stock like this. i believed in this comeback early, so i bought in a month ago at 9. its been a nice run. i am now expecting a little pause, so i may sell some short term calls to take in a little profit.
Dirar Haddadin
Dirar Haddadin Aug 12, 2021 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What is the sxpectations ?
Zoran Labus
Zoran Labus Mar 26, 2021 7:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
alan abbas
alan abbas Feb 18, 2021 10:23AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
check out RIGL
Johnny Walker
Johnny Walker Feb 17, 2021 8:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
28?
Lucas Ang
Lucas Ang Feb 12, 2021 4:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great stock
Mohmoh lolkk
Mohmoh lolkk Dec 18, 2020 10:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
20.000plz
Mohmoh lolkk
Mohmoh lolkk Dec 18, 2020 10:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
20.000plz
Sameer Shah
Sameer Shah Dec 01, 2020 12:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Wow 14.88
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email